Articles tagged as

Food and Drug Administration

  1. How Will E-Cigarettes Affect Big Tobacco?

  2. ETF Analysis: ALPS Medical Breakthroughs

  3. Celgene Vs. Gilead: Vetting for the Best Biopharma

  4. ETF Analysis: Market Vectors Pharmaceutical

  5. 10 Developments By Gilead Sciences That Could Boost Profits

  6. How to Profit from the Generic Drug Trend

  7. How Does Biogen Make its Money?

  8. How NDAs Work and Why They're Important

  9. Could Amgen's Next Drug Be Worth $100 Billion?

  10. 3 Things That Could Hold Intuitive Surgical Back

  11. Did Orexigen Make A Big Mistake?

  12. Are These Biogen Idec's Next Blockbusters?

  13. Why Does Wall Street Hate MannKind?

  14. What’s The Drug That Will Finally Fight Obesity?

  15. Is Ariad On Track To Lose More Shares?

  16. What Is Amgen’s New Target?

  17. Will MannKind Finally Reach A Solid Ground?

  18. What Are The Real Economic Costs Of Obesity?

  19. Gilead Sciences: The New Market-Share Leader

  20. A Checklist For Successful Medical Technology Investment

  21. Getting Started In Stocks

  22. Top 4 Most Scandalous Insider Trading Debacles

  23. 8 Stages Of New Drug Development

  24. Investing In Medical Equipment Companies

  25. Using DCF In Biotech Valuation

  26. Investing In The Biotech Sector

  27. 4 Reasons Why You Love To Hate Big Businesses

  28. Evaluating Pharmaceutical Companies

  29. A Primer On The Biotech Sector

  30. Government Regulations: Do They Help Businesses?

  31. 7 Popular Diet Plans And What They Cost

  32. Baby Boomers Beware: Financial Fraud That Targets Seniors

  33. Scandals That Bring The CEOs Out

  34. Infamous Female Financiers

  35. A Year In Product Recalls

  36. Pharma Patent Trolls: Cheap Drugs At A Steep Price

  37. Investing In The Healthcare Sector

  38. Chasing Down Biotech Zombie Stocks

  39. The Ups And Downs Of Biotechnology

Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!